Education
About Us
Working with TipRanks
Follow Us
Chris Ntoumenopoulos Insider Profile
4 Followers
Chris Ntoumenopoulos, Director at ResApp Health Limited, holds 16.25M shares in Tryptamine Therapeutics (Ticker: AU:TYP), holds 6.97M shares in TrivarX Limited (Ticker: MDBIF), holds 3.61M shares in ResApp Health Limited (Ticker: AU:RAP). Most recently, Chris Ntoumenopoulos Bought ― shares of Tryptamine Therapeutics on Mar 31, 2025 for an estimated value of 200.00K.
Chris Ntoumenopoulos ResApp Health Limited (RAP)Director
ResApp Health Limited (RAP)
Director
Ranked #211 out of 102,596 Corporate Insiders
Profitable Transactions
4 out of 6 Profitable Transactions
Average Return
+231.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Chris Ntoumenopoulos holds in companies
Most Profitable Insider Trade
Stock:
ResApp Health Limited
(RAP)
(RAP)
Rating:Informative Buy
Date:Jul 07, 2015 - Jul 07, 2016
Return:+800.00%
The most profitable trade made by Chris Ntoumenopoulos
Chris Ntoumenopoulos's Trading History
ResApp Health Limited
Mar 16, 2021
―
Informative Buy
35.50K
AU$739.92K
Race Oncology Ltd.
Oct 14, 2019
Senior Officer
Informative Buy
25.00K
AU$1.19M
TrivarX Limited
Dec 05, 2024
Director
Uninformative Buy
20.00K
$167.33K
Tryptamine Therapeutics
Mar 31, 2025
Director
Informative Buy
200.00K
AU$520.00K
List of latest transactions for each holding click on a transaction to see Chris Ntoumenopoulos's performance on stock
You May Also Like
Chris Ntoumenopoulos insider profile FAQ
What is the percentage of profitable transactions made by Chris Ntoumenopoulos?
The percentage of profitable transactions made by Chris Ntoumenopoulos is 67%.
What is the average return per transaction made by Chris Ntoumenopoulos?
The average return per transaction made by Chris Ntoumenopoulos is 231.50%.
What stocks does Chris Ntoumenopoulos hold?
Chris Ntoumenopoulos holds: AU:RAP, AU:RAC, MDBIF, AU:TYP stocks.
What was Chris Ntoumenopoulos’s latest transaction?
Chris Ntoumenopoulos latest transaction was an Informative Buy of AU$200.00K.
What was Chris Ntoumenopoulos's most profitable transaction?
Chris Ntoumenopoulos’s most profitable transaction was an Informative Buy of AU:RAP stock on July 7, 2015. The return on the trade was 800.00%.
What is Chris Ntoumenopoulos's role in ResApp Health Limited?
Chris Ntoumenopoulos's role in ResApp Health Limited is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.